Evidence map›Paper›PMID 14660734›Full record

ReviewThe Journal of clinical investigation2003

Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Shlomo Melmed

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed, 6 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 6 syntheses or guidelines pooled it, 416 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Shlomo MelmedCedars-Sinai Medical Center, David Geffen School of Medicine, University of California, 8700 Beverly Boulevard, Room 2015, Los Angeles, California 90048, USA. melmed@csmc.edu
Cedars-Sinai Medical Center · US

Funding

Mechanisms of Pituitary TumorigenesisR01CA075979 · NCI · CEDARS-SINAI MEDICAL CENTER · PI MELMED, SHLOMO · 1999 to 2012
$3.5M
Metabolic consequences of securin disruptionR01DK064169 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MELMED, SHLOMO · 2003 to 2007
$1.6M
NCI NIH HHS CA75979NCI NIH HHS R01 CA075979NIDDK NIH HHS DK64169NIDDK NIH HHS R01 DK064169
6 · The paper itself

Abstract

The anterior pituitary gland integrates the repertoire of hormonal signals controlling thyroid, adrenal, reproductive, and growth functions. The gland responds to complex central and peripheral signals by trophic hormone secretion and by undergoing reversible plastic changes in cell growth leading to hyperplasia, involution, or benign adenomas arising from functional pituitary cells. Discussed herein are the mechanisms underlying hereditary pituitary hypoplasia, reversible pituitary hyperplasia, excess hormone production, and tumor initiation and promotion associated with normal and abnormal pituitary differentiation in health and disease.

Indexed as

AdenomaAnimalsChromosomal InstabilityEstrogensGenes, Tumor SuppressorHumansHyperplasiaHypothalamusLoss of HeterozygosityMultiple Endocrine NeoplasiaNeoplasm ProteinsPituitary GlandPituitary NeoplasmsSecurinEstrogensNeoplasm ProteinsSecurin

Identifiers

PMID14660734
PMCPMC281651
OpenAlexW2020899639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.